CREE INC
424B3, 2000-03-30
SEMICONDUCTORS & RELATED DEVICES
Previous: DIAMETRICS MEDICAL INC, 10-K, 2000-03-30
Next: MORGAN STANLEY DEAN WITTER & CO, 424B3, 2000-03-30



                                                Filed pursuant to Rule 424(b)(3)
                                                                 and Rule 424(c)
                                                       Registration No. 33-98728

                                   CREE, INC.

                              PROSPECTUS SUPPLEMENT
                              Dated March 29, 2000

            To Prospectus dated December 18, 1995, as supplemented by
                  the Prospectus Supplement dated May 24, 1996

The attached Prospectus for Cree, Inc.,  formerly known as Cree Research,  Inc.,
is hereby supplemented as follows:

Professional  Edge Fund,  L.P.,  which is listed in the  Prospectus as a selling
shareholder,  has assigned and transferred to Susquehanna Capital Group warrants
to purchase  20,000 shares of Cree's  common stock (as adjusted  pursuant to the
2-for-1  stock  split of Cree's  common  stock  effective  July 26,  1999).  The
following  table  sets  forth  certain  information  which  amends  the  selling
shareholders table of the Prospectus.  Neither Professional Edge nor Susquehanna
is an  affiliate  of Cree nor has either had a material  relationship  with Cree
during the past three years.

<TABLE>
<CAPTION>
                                                                             Percent of
                         No. of Shares of                    Shares         Common Stock
                           Common Stock         No. of     Beneficially     Owned After
                        Beneficially Owned      Shares     Owned After     Completion of
Name                   at March 1, 2000 (1)   Offered (1)  Offering (2)       Offering
- ----                   --------------------   -----------  ------------    -------------
<S>                    <C>                    <C>          <C>             <C>
Professional Edge                0                 0            0                -
Fund, L.P.
Susquehanna Capital           20,000            20,000          0                -
Group
</TABLE>

- ---------------

(1) Consists solely of common stock issuable to the selling shareholder upon the
    exercise of  currently exerciseable  warrants  to purchase  shares of common
    stock at an exercise price of $13.6125 per share.

(2) Assumes that all shares of common stock  offered by the selling  shareholder
    are sold.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission